Cholesterol confers resistance to Apatinib-mediated ferroptosis in gastric cancer

Abstract Background Gastric cancer is the fifth leading cause of cancer-related deaths worldwide. Apatinib is a third-line treatment for gastric cancer. However, the development of resistance significantly limits its efficacy, and effective and safe strategies to overcome Apatinib resistance remain...

Full description

Bibliographic Details
Published in:Cell & Bioscience
Main Authors: Zhiwei Li, Chenxin Liu, Minghao Wang, Riqing Wei, Ru Li, Kaihua Huang, Huayuan Liang, Guoxin Li, Liying Zhao
Format: Article
Language:English
Published: BMC 2025-07-01
Subjects:
Gastric cancer
Apatinib
Ferroptosis
Cholesterol
HMGCR
Online Access:https://doi.org/10.1186/s13578-025-01435-5

Internet

https://doi.org/10.1186/s13578-025-01435-5

Similar Items